Methylene Blue Versus Vasopressin Analogue for Treatment of Septic Shock in Preterm Neonate

NCT04110418 PHASE2 UNKNOWN

A randomized, prospective study comparing methylene blue versus terlipressin in treatment of catecholamines resistant shock in preterm neonate

Details

Lead sponsor	Ain Shams University
Phase	PHASE2
Status	UNKNOWN
Enrolment	36
Start date	Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Feb 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Neonatal Sepsis
• Refractory Shock

Interventions

• Methylene Blue

Countries

Egypt